Showing results (1-10 of 587) with videos related to
Sort By:
Pageof 59
Anticancer Research|May 1, 1987
Unexpected normal serum beta-microglobulin (B2M) levels in multiple myelomaR Bataille, J Grenier, J SanyBlood|February 1, 1984
Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patientsR Bataille, J Grenier, J SanyJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Prognostic factors and staging in multiple myeloma: a reappraisalR Bataille, B G Durie, J Grenier, et al.European Journal of Cancer & Clinical Oncology|January 1, 1982
Serum beta-2-microglobulin in multiple myeloma: relation to presenting features and clinical statusR Bataille, M Magub, J Grenier, et al.Metabolic Bone Disease & Related Research|January 1, 1982
Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitoninR Bataille, J SanyCancer|August 1, 1981
Solitary myeloma: clinical and prognostic features of a review of 114 casesR Bataille, J SanyRevue Du Rhumatisme Et Des Maladies Osteo-Articulaires|March 1, 1981
[Serum beta-2-microglobulin in multiple myeloma. Practical value]R Bataille, M Magub, J Sany, et al.Presse Medicale (Paris, France : 1983)|October 11, 1986
[Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma]R Bataille, J GrenierAnticancer Research|November 1, 1984
Clinical evaluation of response or escape to chemotherapy and of survival of patients with multiple myeloma. A prospective study of 202 patients (1975-1982)R Bataille, P Souteyrand, J SanyLa Nouvelle Presse Medicale|February 14, 1981
[Apparently isolated plasmacytoma of bone. Clinical and prognostic data. 114 cases and review of literature (author's transl)]R Bataille, J Sany, H SerrePageof 59